Hyper-Progressive Disease on Immunotherapy in Advanced NSCLC (BMIC-012)

BeaconMedIC has 15 videos Subscribe Here

Description: Dr. Jack West reviews evidence that a subset of patients with advanced NSCLC demonstrate "hyper-progressing disease" (HPD), worsening cancer at a faster rate, on immune checkpoint inhibitor therapy, more commonly than seen in patients on chemotherapy.
Shared By : BeaconMedIC
Posted on : 10/27/17
Added : 26 days ago
Category : Immunotherapy

More From BeaconMedIC

Nothing found.